+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Depyrogenated Sterile Empty Vials Market by Product Type, Application, End User, Capacity, Sterilization Method - Global Forecast to 2030- Product Image
Depyrogenated Sterile Empty Vials Market by Product Type, Application, End User, Capacity, Sterilization Method - Global Forecast to 2030- Product Image
Sale

Depyrogenated Sterile Empty Vials Market by Product Type, Application, End User, Capacity, Sterilization Method - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977973
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The depyrogenated sterile empty vials market is evolving rapidly, shaped by innovation in materials, regulatory pressures, and increasing demand across pharmaceutical and biotechnology applications. Senior decision-makers face both opportunities and challenges as new technologies and sourcing strategies redefine market dynamics.

Market Snapshot: Depyrogenated Sterile Empty Vials Market Outlook

The depyrogenated sterile empty vials market grew from USD 846.93 million in 2024 to USD 907.03 million in 2025. This sector is set to advance at a CAGR of 6.77%, and is projected to reach USD 1.25 billion by 2030. Robust downstream demand for life sciences applications and new therapeutics continues to sustain market growth, particularly as manufacturers respond to complex requirements for sterility, product integrity, and compliance in global supply chains.

Scope & Segmentation

The market is defined by diverse segments, each influencing supply chain priorities and product strategies. This scope provides clarity for organizations seeking optimization opportunities.

  • Container Types: Both glass and plastic sterile vials are significant, with amber and clear options within glass, and polyethylene and polypropylene driving plastic adaptation.
  • Material Types: High-performance polymers are gaining traction, offering shatter resistance and chemical compatibility that position them as viable alternatives to glass.
  • Applications: Key areas include cell and gene therapy in biotechnology, diagnostic workflows, injectables, and vaccines for broad immunization campaigns.
  • End Users: Demand comes from biotechnology firms, diagnostic laboratories (hospital-based and independent), pharmaceuticals (generic and innovator), hospitals (public and private), and research institutes.
  • Container Sizes: Selections range from up to 2 mL to capacities above 10 mL, impacting suitability for dosing, storage, and logistics management.
  • Sterilization Technologies: Autoclave, ethylene oxide, and gamma radiation processes are central to ensuring compliance with endotoxin standards across vial types.
  • Key Regions: The Americas, Europe, Middle East & Africa, and Asia-Pacific are primary markets, each exhibiting unique regulatory and sourcing environments that affect provider choices.

Key Takeaways for Decision-Makers

  • Material innovation, especially in polymer chemistry, is changing the landscape, reducing dependence on traditional glass and supporting supply chain resiliency.
  • Process automation and digital traceability systems are critical for achieving compliance and accelerating time-to-market for new therapies.
  • Sustainability considerations, such as recyclable materials and energy-efficient sterilization, are increasingly shaping procurement policies, aligned with corporate environmental goals.
  • Strategic alliances between vial manufacturers and contract service organizations are emerging as a core route to value, driving end-to-end solutions and process optimization.
  • Regional market dynamics necessitate tailored go-to-market strategies; capacity building in the Americas and rapid industrialization in Asia-Pacific require differentiated responses.
  • Portfolio flexibility, enabling seamless shifts between glass and polymer production, positions suppliers to address evolving customer needs and manage market fluctuations.

Tariff Impact: 2025 U.S. Tariff Shifts and Strategic Response

The upcoming revisions to U.S. tariffs on imported depyrogenated sterile vials will alter sourcing economics and may accelerate investment in domestic production. Manufacturers reliant on transpacific supply chains should reassess risk exposures, while partnerships with local sterilization providers may offer mitigation strategies. Pharmaceutical and biotech buyers will likely diversify sources, increasing preference for plastic vials where cost and compliance conditions are met. These developments will catalyze realignment of both capacity and supply chain architecture throughout the sector.

Methodology & Data Sources

This analysis leverages a multi-phase methodology: comprehensive review of secondary sources, followed by in-depth primary interviews with stakeholders across the ecosystem. Quantitative inputs were validated through extensive market surveys, with findings triangulated against shipment and tariff data, and refined in expert roundtables.

Why This Report Matters

  • Supports strategic investment by mapping the evolving landscape in sterile vial manufacturing, material science, and regulatory frameworks.
  • Empowers procurement and operational leaders to optimize sourcing choices, supply chain resilience, and innovation alignment.
  • Provides actionable insights for tailoring product portfolios and market entry strategies to distinct regions and end-user profiles.

Conclusion

The depyrogenated sterile empty vials market is entering a period of transformation driven by technological, regulatory, and supply chain shifts. Organizations positioned with flexible, innovative approaches will secure long-term growth and resilience in an increasingly complex global environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Depyrogenated Sterile Empty Vials Market, by Product Type
8.1. Introduction
8.2. Glass Vials
8.2.1. Amber
8.2.2. Clear
8.3. Plastic Vials
8.3.1. Polyethylene
8.3.2. Polypropylene
9. Depyrogenated Sterile Empty Vials Market, by Application
9.1. Introduction
9.2. Biotechnology
9.2.1. Cell Therapy
9.2.2. Gene Therapy
9.3. Diagnostics
9.3.1. Clinical Chemistry
9.3.2. Immunodiagnostics
9.3.3. Molecular Diagnostics
9.4. Injectables
9.5. Vaccines
9.5.1. COVID-19
9.5.2. Influenza
10. Depyrogenated Sterile Empty Vials Market, by End User
10.1. Introduction
10.2. Biotechnology Firms
10.3. Diagnostic Laboratories
10.3.1. Hospital Based Laboratories
10.3.2. Independent Laboratories
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
10.5. Pharmaceutical Companies
10.5.1. Generic Manufacturers
10.5.2. Innovator Companies
10.6. Research Institutes
10.6.1. Academic Institutions
10.6.2. Government Research Centers
11. Depyrogenated Sterile Empty Vials Market, by Capacity
11.1. Introduction
11.2. Above 10 Ml
11.3. Above 2 To 5 Ml
11.4. Above 5 To 10 Ml
11.5. Up To 2 Ml
12. Depyrogenated Sterile Empty Vials Market, by Sterilization Method
12.1. Introduction
12.2. Autoclave
12.3. Ethylene Oxide
12.4. Gamma Radiation
13. Americas Depyrogenated Sterile Empty Vials Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Depyrogenated Sterile Empty Vials Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Depyrogenated Sterile Empty Vials Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Schott AG
16.3.2. Gerresheimer AG
16.3.3. Stevanato Group SpA
16.3.4. Corning Incorporated
16.3.5. Nipro Corporation
16.3.6. Piramal Glass Limited
16.3.7. Becton, Dickinson and Company
16.3.8. Nippon Electric Glass Co., Ltd.
16.3.9. Hi-Tech Pharmaceutical Glass Co., Ltd.
16.3.10. Cardinal Health, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET MULTI-CURRENCY
FIGURE 2. DEPYROGENATED STERILE EMPTY VIALS MARKET MULTI-LANGUAGE
FIGURE 3. DEPYROGENATED STERILE EMPTY VIALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DEPYROGENATED STERILE EMPTY VIALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DEPYROGENATED STERILE EMPTY VIALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AMBER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLEAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COVID-19, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INNOVATOR COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 10 ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 2 TO 5 ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 5 TO 10 ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY UP TO 2 ML, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AUTOCLAVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GAMMA RADIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 87. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 89. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 90. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 93. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 94. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 96. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 97. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 98. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 99. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 100. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 101. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 107. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 108. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 110. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 112. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 113. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 114. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 172. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 174. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 175. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 178. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 179. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 181. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 183. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 184. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 185. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 186. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 188. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 189. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 192. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 193. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 195. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 196. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 197. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 198. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 199. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 214. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 216. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 217. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 220. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 221. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 223. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 225. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 226. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 227. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 228. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 230. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 231. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 234. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 235. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 237. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 238. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 239. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 240. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 241. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 256. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 270. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 272. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
TABLE 284. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2030 (USD MILLION)
TABLE 286. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2030 (USD MILLION)
TABLE 287. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 289. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 290. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 291. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 293. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 294. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Depyrogenated Sterile Empty Vials market report include:
  • Schott AG
  • Gerresheimer AG
  • Stevanato Group SpA
  • Corning Incorporated
  • Nipro Corporation
  • Piramal Glass Limited
  • Becton, Dickinson and Company
  • Nippon Electric Glass Co., Ltd.
  • Hi-Tech Pharmaceutical Glass Co., Ltd.
  • Cardinal Health, Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 907.03 Million
Forecasted Market Value ( USD ) by 2030 $ 1250 Million
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Depyrogenated Sterile Empty Vials Market Report 2025 - Product Image

Depyrogenated Sterile Empty Vials Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cryogenic Vials Market by Material, End User, Application, Volume, Sterility, Closure, Automation Compatibility - Global Forecast to 2030 - Product Image

Cryogenic Vials Market by Material, End User, Application, Volume, Sterility, Closure, Automation Compatibility - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Medical Device Packaging Market by Type, Material Type, Sterilization Method Compatibility, Packaging Level, Packaging Formats, Device Type, Packaging Type, Application, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Medical Device Packaging Market by Type, Material Type, Sterilization Method Compatibility, Packaging Level, Packaging Formats, Device Type, Packaging Type, Application, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Pharmaceutical Glass Vials And Ampoules - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Pharmaceutical Glass Vials And Ampoules - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 154 Pages
  • Global
From
Vaccine Vials Market 2025-2033 - Product Image

Vaccine Vials Market 2025-2033

  • Report
  • 142 Pages
  • Global
From

About the Depyrogenated Sterile Empty Vials Market

The Depyrogenated Sterile Empty Vials market is a subset of the Drug Discovery industry. It is a specialized market that focuses on the production of sterile, empty vials that have been depyrogenated. This process involves the removal of pyrogens, which are substances that can cause fever in humans. Depyrogenated vials are used in the production of injectable drugs, and are essential for ensuring the safety of the drug. The market is highly regulated, and manufacturers must adhere to strict quality standards. The Depyrogenated Sterile Empty Vials market is highly competitive, with many companies offering a range of products. Some of the major players in the market include West Pharmaceutical Services, Inc., Nipro Corporation, Schott AG, and Corning Incorporated. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.